Moneycontrol

You are Here : See 20% EBITDA growth in FY14: Alembic Pharma

Wednesday, 03:50

In an interview to CNBC-TV18, Amin adds that the company, despite the drug pricing policy, will grow at 15 percent.
SEP 24, 2017
05:17 AM

cnbc tv18 shows

Search
All Shows
Go

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Sections
Follow us on
Available On